You have reached the HIVandHepatitis.com legacy site. Please visit our new site at hivandhepatitis.com

Hepatitis A Immune Response Has Implications for Hepatitis C

SUMMARY
Hepatitis A virus appears to evade immune defenses better than hepatitis C virus, even though it only causes short-term illness. Learning about differences between viral dynamics and immune response to HAV and HCV may offer information that can inform treatment.

Hepatitis A virus (HAV) is a picornavirus that causes only acute infection, as the immune system can clear the virus its own without treatment. Hepatitis C virus (HCV), in contrast, is a flavivirus that often causes chronic infection. The main similarity is that the 2 viruses both target the liver.

As described in the July 5, 2011, Proceedings of the National Academy of Sciences USA, Robert Lanford from the Texas Biomedical Research Institute and colleagues compared viral activity and immune response to HAV and HCV in chimpanzees.

Below is an edited excerpt from a press release issued by the Southwest Foundation for Biomedical Research describing the study and its findings.

New Study Reveals How the Immune System
Responds to Hepatitis A Virus

Has implications for future of hepatitis C research

June 20, 2011 -- A surprising finding in a study comparing hepatitis C virus (HCV) with hepatitis A virus (HAV) infections in chimpanzees by a team that includes scientists from the Texas Biomedical Research Institute sheds new light on the nature of the body's immune response to these viruses.

Understanding how hepatitis C becomes chronic is very important because some 200 million people worldwide and 3.2 million people in the U.S. are chronically infected with HCV and are at risk for progression to cirrhosis and liver cancer. Hepatitis C associated liver disease is the most common indication for liver transplantation, while liver cancer due to HCV infection is now the most rapidly increasing cause of cancer death in the U.S.

"Remarkably, we found that HAV was more adept at evading the innate immune response than HCV, the virus that ultimately causes chronic infections," said Robert E. Lanford, PhD, a Texas Biomed virologist. The novel findings demonstrate that HAV is the stealthier virus when it comes to evading the innate immune response, despite the lack of persistent infections.

Hepatitis C infections are characterized by a failure of the immune system to combat and eliminate the virus. "We suspect this failure of the immune system shares attributes with other persistent viruses such as HIV and hepatitis B virus," said Lanford. By comparing two similar viruses that infect the liver, one that is always cleared by the immune system, HAV, and one that frequently evades the immune response, HCV, the team hoped to unravel the mystery of how HCV causes lifelong persistent infections.

The research team involved scientists from Texas Biomed in San Antonio, the University of North Carolina (UNC) at Chapel Hill, and Nationwide Children's Hospital in Columbus, Ohio. The study performed in chimpanzees at Texas Biomed's Southwest National Primate Research Center (SNPRC) and funded by the National Institutes of Health, is published today in Proceedings of the National Academy of Sciences U.S.A.

The new study points out the critical need for more information about how the immune system reacts to HCV. It also reinforces the importance of chimpanzee research in this effort. The chimpanzee, the only animal model susceptible to HCV infection, was critical for probing the molecular differences in gene expression in the liver related to infection by the two viruses.

Examination of the adaptive immune system by co-author Christopher M. Walker, PhD, of Nationwide Children's Hospital in Columbus, Ohio, found that the T cell response to HAV was unique as well. "We expected the immune response to kill all HAV infected cells in a short time frame, and yet we could detect the genome of the virus in the liver for up to one year, long after symptoms of the disease were resolved," Lanford explained.

"Hepatitis viruses have co-evolved with humans over a very long period of time and they are good at evading the immune system, but nobody understands how hepatitis C becomes a chronic infection," said co-author Stanley M. Lemon, MD, of UNC.

"The surprising and exciting results of this research program further highlight the critical value of the chimpanzee model in research on hepatitis," said John L. VandeBerg, PhD, Texas Biomed's chief scientific officer and SNPRC director.

Investigator affiliations: Department of Virology and Immunology, Texas Biomedical Research Institute, and Southwest National Primate Research Center, San Antonio, TX; Division of Infectious Diseases, Department of Medicine, Center for Translational Immunology, and the Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC; Center for Vaccines and Immunity, Research Institute at Nationwide Children's Hospital, Columbus, OH; Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, NM.

7/8/11

Reference
RE Lanford, Z Feng, D Chavez, et al. Acute hepatitis A virus infection is associated with a limited type I interferon response and persistence of intrahepatic viral RNA. Proceedings of the National Academy of Sciences USA 108(27):11223-11228 (abstract). July 5, 2011.

Other Sources

Southwest Foundation for Biomedical Research. New Study Reveals How the Immune System Responds to Hepatitis A Virus. Press release. June 20, 2011.

University of North Carolina School of Medicine. Acute Hepatitis A Evades Immune System More Effectively than Chronic Cousin. Press release. June 20, 2011.




 


 


 


 






 



 




 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 Google Custom Search
 
Experimental Treatments
Treatment Guidelines

HCV Articles by Topic

Cirrhosis
Fibrosis
Hepatocellular Carcinoma
Liver Transplantation
Liver Biopsy

Steatosis
Anemia
Children / Infants / Women
Drug Abuse
Experimental Treatments
FAQs About Hepatitis C
Genotypes
Insulin Resistance / Diabetes
Sustained Viral Response (SVR)
Tests for HCV
Vaccines for HCV